Anne‐Christine Cascais

Minimizing DILI risk in drug discovery — A screening tool for drug candidates

Simone Schadt, Silke Simon, Stefan Kustermann et al. · Toxicology in Vitro · 2015 · 88 citations

Drug Target, Hit Identification, Drug Candidates +8

Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data

Agnès Poirier, Anne‐Christine Cascais, Christoph Funk et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2009 · 80 citations

Medicinal Chemistry, Pharmacokinetic Modeling, Pharmacodynamics +11

Calibration of In Vitro Multidrug Resistance Protein 1 Substrate and Inhibition Assays as a Basis to Support the Prediction of Clinically Relevant Interactions In Vivo

Agnès Poirier, Anne‐Christine Cascais, Urs Bader et al. · Drug Metabolism and Disposition · 2014 · 46 citations

The Need for Human Breast Cancer Resistance Protein Substrate and Inhibition Evaluation in Drug Discovery and Development: Why, When, and How?

Agnès Poirier, Renée Portmann, Anne‐Christine Cascais et al. · Drug Metabolism and Disposition · 2014 · 46 citations

Prediction of Pharmacokinetic Profile of Valsartan in Humans Based on<i>in vitro</i>Uptake‐Transport Data

Agnès Poirier, Anne‐Christine Cascais, Christoph Funk et al. · Chemistry & Biodiversity · 2009 · 34 citations